文献速递细菌感染、耐药与抗菌药物医院感染防控

替加环素耐药鲍曼不动杆菌的基因组分析揭示医院谱系变迁和新耐药机制

Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms.
PubMed 文献 · J Antimicrob Chemother · 2024-01-01

该研究分析了2016至2021年来自中国某医院的64株替加环素耐药鲍曼不动杆菌(TRAB),通过全基因组测序、系统发育分析及基因表达和克隆实验,揭示了克隆动态和耐药突变;研究发现KL7克隆自2019年出现并成为优势克隆,且携带更多耐药基因,鉴定了11种新的AdeS突变及一种质粒介导的tet(39)变异(Ala-36-Thr),可协同外排泵导致高水平替加环素耐药。

要点

  • 2016至2021年某中国医院64株TRAB中95%(61/64)对碳青霉烯类耐药。
  • KL2克隆持续存在,KL7克隆于2019年出现并成为优势克隆,携带更多耐药基因。
  • KL2和KL7的主要替加环素耐药机制分别为adeN插入序列(82.1%,23/28)和adeS基因改变(76.2%,16/21)。

核心结论

  • 本研究揭示了鲍曼不动杆菌替加环素耐药机制的多样性,并强调临床环境中需进一步监测ST2-KL7鲍曼不动杆菌。

研究设计与样本

  • 研究纳入2016至2021年中国某医院64株替加环素耐药鲍曼不动杆菌(TRAB),进行全基因组测序、系统发育分析及非多态性突变分析,并用RT-PCR分析adeB和adeJ外排泵基因表达,基因克隆探索tet(39)变异对替加环素耐药的影响。

主要发现

  • 64株TRAB中95%(61/64)对碳青霉烯类耐药,基于核心基因组SNP分为三个主要遗传簇。
  • KL2簇贯穿研究期间,KL7簇于2019年出现并成为优势克隆,且KL7簇携带的抗菌药物耐药基因多于其他两簇。
  • KL2簇的主要替加环素耐药机制为adeN插入序列(82.1%,23/28),KL7簇为adeS基因改变(76.2%,16/21)。
  • 鉴定出11种新的AdeS突变,与AdeB表达升高和替加环素耐药相关。
  • 表征了一种质粒介导的tet(39)变异(Ala-36-Thr替换),可与RND外排泵协同导致高水平替加环素耐药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the characteristics and clonal dynamics of tigecycline-resistant Acinetobacter baumannii (TRAB) isolates from a Chinese hospital from 2016 to 2021. METHODS: A total of 64 TRAB isolates were screened and WGS was performed. Phylogenetic analysis and non-polymorphic mutation analysis were used to analyse their clonal dynamics and tigecycline resistance-related mutations. RT-PCR was used to analyse the expression of the resistance-nodulation cell-division (RND) efflux pump genes adeB and adeJ. Gene cloning was used to explore the effect of tet(39) variants on tigecycline resistance. RESULTS: Most TRAB isolates were found to be MDR, with 95% (61/64) of the isolates showing resistance to carbapenems. These TRAB isolates were classified into three primary genetic clusters based on core-genome SNPs. The KL2 cluster persisted throughout the study period, whereas the KL7 cluster emerged in 2019 and became the dominant clone. The KL7 cluster carried more antimicrobial resistance genes than the other two clusters. The predominant tigecycline resistance mechanism of the KL2 cluster and KL7 cluster was IS insertion in adeN (82.1%, 23/28) and genetic alterations in adeS (76.2%, 16/21), respectively. Eleven novel AdeS mutations were identified associated with elevated AdeB expression and tigecycline resistance. Moreover, we characterized a plasmid-borne tet(39) variant with an Ala-36-Thr substitution that synergizes with the RND efflux pump to confer high-level tigecycline resistance. CONCLUSIONS: This work provides important insights into the diverse mechanisms associated with tigecycline resistance in A. baumannii, highlighting a pressing need for further monitoring of ST2-KL7 A. baumannii in clinical settings.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Qian C, Hu P, Guo W, et al. Genome analysis of tigecycline-resistant Acinetobacter baumannii reveals nosocomial lineage shifts and novel resistance mechanisms. J Antimicrob Chemother. 2024. PMID: 39287979. doi:10.1093/jac/dkae314

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。